Barry H. Dash
Barry H. Dash has made 1 open-market purchase worth $26k since Oct 19, 2026, in 1 company. The latest: $26k of ELTP, filed Oct 19, 2026, scored 5 out of 100.
Director, ELITE PHARMACEUTICALS INC /NV/
Follow Barry H. Dash, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 19 Form 4 (opens sec.gov) |
ELTPELITE PHARMACEUTICALS INC /NV/ · DirectorDirector · Filed late · Penny stock: hard to trade | +3% stake | 5 | $26k 100,000 at $0.26 |
−0.6% | waiting |
Track record (hypothetical): a week after the filing, these buys averaged −0.6% (0% up, 1 measured).
Questions
What stock has Barry H. Dash bought?
ELTP (ELITE PHARMACEUTICALS INC /NV/), all on the open market and reported on SEC Form 4.
When did Barry H. Dash last buy?
Oct 19, 2026: 100,000 shares of ELTP at $0.26, $26k in all (Form 4 (opens sec.gov)).
Has Barry H. Dash filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Barry H. Dash a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Oct 19, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer